[en] Chronic kidney disease (CKD) is a worldwide public health problem. Little is known about its burden in Africa. This paper reviews the knowledge of CKD in Kinshasa, summarizing four studies undertaken in the general population and traditional health system of Kinshasa. CKD was defined by either kidney damage (proteinuria 300 mg/day) or reduced kidney function (eGFR < 60 ml/min/1.73 m2). In the general population, the prevalence of CKD all stage is 12.4 %. Our work shows also the high prevalence of proteinuria among subjects who do not have diabetes or hypertension, the lack of early detection and management of CKD risk factors in the traditional health care system leading to late referral or premature deaths, and the limits of renal replacement treatment. CKD affects young people in the DRC, in contrast to the United States, where CKD is more prevalent in older people. Major determinants of CKD in our studies were hypertension, diabetes, overweight, age, lower socioeconomic status, and Human immunodeficiency virus (HIV) infection. Glomerular nephropathy (mainly focal segmental glomerulosclerosis) remains the leading cause of end stage renal disease. An annual screening of the population for proteinuria and CKD risk factors is feasible and will, it is hoped, provide the basis for building a nationwide prevention strategy.
Disciplines :
Urology & nephrology
Author, co-author :
Sumaili, E. K.; Université de Kinshasa > Service de néphrologie, cliniques universitaires de Kinshasa
L.A. Stevens, J. Coresh, H.I. Feldman, T. Greene, J.P. Lash, and R.G. Nelson Evaluation of the modification of diet in renal disease study equation in a large diverse population J Am Soc Nephrol 18 2007 2749 2757
United States Renal Data System: USRDS 203 Annual Data Report. Atlas of end stage renal disease in the United States. In: USRD Adr (editor), Bethesda, MD, National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases, 2003.
R.S. Barsoum Chronic kidney disease in the developing world N Engl J Med 354 2006 997 999
Frimat L, Loos-Ayay C, Brianon S, Kessler M. Épidémiologie des maladies rénales chroniques. (Elsevier SAS, Paris), Néphrologie 2005:18-025-A-010.
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
J. Coresh, E. Selvin, L.A. Stevens, J. Manzi, J.W. Kusek, and P. Eggers Prevalence of chronic kidney disease in the United States JAMA 298 2007 2038 2047
V. Perkovic, A. Cass, A.A. Patel, P. Suriyawongpaisal, F. Barzi, and S. Chadban High prevalence of chronic kidney disease in Thailand Kidney Int 73 2008 473 479
A. Otero, P. Gayoso, F. Garcia, and A.L. de Francisco Epidemiology of chronic renal disease in the Galician population: results of the pilot Spanish EPIRCE study Kidney Int Suppl 2005 S16 19
L. Zhang, L. Zuo, G. Xu, F. Wang, M. Wang, and S. Wang Community-based screening for chronic kidney disease among populations older than 40 years in Beijing Nephrol Dial Transplant 22 2007 1093 1099
S.I. Hallan, J. Coresh, B.C. Astor, A. Asberg, N.R. Powe, and S. Romundstad International comparison of the relationship of chronic kidney disease prevalence and ESRD risk J Am Soc Nephrol 17 2006 2275 2284
T. Ninomiya, Y. Kiyohara, M. Kubo, Y. Tanizaki, Y. Doi, and K. Okubo Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study Kidney Int 68 2005 228 236
W.F. Clark, J.J. Macnab, S.J. Chen, R. Suri, L. Moist, and A.X. Garg Evaluation of GFR estimating equations in the general community: implications for screening Clin J Am Soc Nephrol 1 2006 787 795
M. Cirillo, M. Laurenzi, M. Mancini, A. Zanchetti, C. Lombardi, and N.G. De Santo Low glomerular filtration in the population: prevalence, associated disorders, and awareness Kidney Int 70 2006 800 806
O. Viktorsdottir, R. Palsson, M.B. Andresdottir, T. Aspelund, V. Gudnason, and O.S. Indridason Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults Nephrol Dial Transplant 20 2005 1799 1807
S. Naicker End-stage renal disease in sub-Saharan and South Africa Kidney Int Suppl 83 2003 S119 S122
E.L. Bamgboye End-stage renal disease in sub-Saharan Africa Ethn Dis 16 2006 S2-5-9
N.M. Pakasa, and E.K. Sumaili The nephrotic syndrome in the Democratic Republic of Congo N Engl J Med 354 2006 1085 1086
Sumaili EK. Épidémiologie de la Maladie Rénale Chronique Kinshasa (en RD. Congo). Thse de doctorat 2009 ; Belgique.
A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, and S. Hendriksen Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
E.K. Sumaili, N.M. Nseka, F.B. Lepira, J.M. Krzesinski, J.R. Makulo, and J.B. Bukabau Screening for proteinuria and chronic kidney disease risk factors in Kinshasa: a World Kidney Day 2007 study Nephron Clin Pract 110 2008 c220 228
E.K. Sumaili, J.M. Krzesinski, C.V. Zinga, E.P. Cohen, P. Delanaye, and S.M. Munyanga Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo Nephrol Dial Transplant 24 2009 117 122
E.K. Sumaili, N.M. Nseka, J.R. Makulo, C.V. Zinga, A.L. Longo, and S.K. Mukendi Statut socioéconomique et protéinurie : résultats de la campagne de dépistage des maladies de rein 2007 Kinshasa Ann Afr Med 2 2009 170 175
E.K. Sumaili, E.P. Cohen, C.V. Zinga, J.M. Krzesinski, N.M. Pakasa, and N.M. Nseka High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo BMC Nephrol 10 2009 18
J. Coresh, B.C. Astor, T. Greene, G. Eknoyan, and A.S. Levey Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12
O. Ifudu Excess burden of end stage renal disease in Blacks: Are we doing enough? Dial Transplant 34 2005 742 744
J.B. Kopp, M.W. Smith, G.W. Nelson, R.C. Johnson, B.I. Freedman, and D.W. Bowden MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis Nat Genet 40 2008 1175 1184
B.I. Freedman, and J.R. Sedor Hypertension-associated kidney disease: perhaps no more J Am Soc Nephrol 19 2008 2047 2051
B.I. Freedman, J.B. Kopp, C.A. Winkler, G.W. Nelson, D.C. Rao, and J.H. Eckfeldt Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study Am J Nephrol 29 2009 626 632
B.I. Freedman, P.J. Hicks, M.A. Bostrom, M.E. Cunningham, Y. Liu, and J. Divers Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans Kidney Int 75 2009 736 745
B.I. Freedman, P.J. Hicks, M.A. Bostrom, M.E. Comeau, J. Divers, and A.J. Bleyer Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD Nephrol Dial Transplant 2009 3366 3371
E.I. Bieleli, J.L. Moswa, K. Kandjingu, P.M. Mulumba, and M. Mayangi Prévalence du diabte sucré au sein de la population de Kinshasa Congo Med 15 2000 1055 1061
J.K. Mbuyamba, R.H. Fagard, and J. Staessen Blood pressure in Bantou of Zaire: epidemiology aspects Trop Cardiol 13 1987 S113 S120
M. Wendorf, and I.D. Goldfine Archaeology of NIDDM. Excavation of the "thrifty" genotype Diabetes 40 1991 161 165
J. Frenk, C.J.L. Murray, and J.L. Babadilla Health transition in middle-income countries: new challenges for healthcare Health Policy Plan 4 1988 29 39
L.E. Boulware, B.G. Jaar, M.E. Tarver-Carr, F.L. Brancati, and N.R. Powe Screening for proteinuria in US adults: a cost-effectiveness analysis JAMA 290 2003 3101 3114
P.E. de Jong, and R.T. Gansevoort Fact or fiction of the epidemic of chronic kidney disease - let us not squabble about estimated GFR only, but also focus on albuminuria Nephrol Dial Transplant 23 2008 1092 1095
J. Addo, L. Smeeth, and D.A. Leon Hypertension in sub-saharan Africa: a systematic review Hypertension 50 2007 1012 1018
A.H. Brantsma, S.J. Bakker, D. de Zeeuw, P.E. de Jong, and R.T. Gansevoort Urinary albumin excretion as a predictor of the development of hypertension in the general population J Am Soc Nephrol 17 2006 331 335
A.H. Brantsma, S.J. Bakker, H.L. Hillege, D. de Zeeuw, P.E. de Jong, and R.T. Gansevoort Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes Diabetes Care 28 2005 2525 2530
H.J. Chin, J.M. Ahn, K.Y. Na, D.W. Chae, T.W. Lee, and N.J. Heo The effect of the World Kidney Day campaign on the awareness of chronic kidney disease and the status of risk factors for cardiovascular disease and renal progression Nephrol Dial Transplant 25 2010 413 419
J. Coresh, G.L. Wei, G. McQuillan, F.L. Brancati, A.S. Levey, and C. Jones Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 161 2001 1207 1216
M.J. Sarnak, T. Greene, X. Wang, G. Beck, J.W. Kusek, and A.J. Collins The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study Ann Intern Med 142 2005 342 351
A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. The Seventh Report of the Joint National Committee on Prevention, Detection. Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
W.C. Cushman Are there benefits to specific antihypertensive drug therapy? Am J Hypertens 16 2003 31S 35S
P.E. Stevens, D.J. O'Donoghue, S. de Lusignan, J. Van Vlymen, B. Klebe, and R. Middleton Chronic kidney disease management in the United Kingdom: NEOERICA project results Kidney Int 72 2007 92 99
J.M. Krzesinski, E.K. Sumaili, and E. Cohen How to tackle the avalanche of chronic kidney disease in sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example Nephrol Dial Transplant 22 2007 332 335
B. Diouf, A. Niang, E.H. Ka, M. Badiane, and T. Moreira Diop [Chronical renal failure in one Dakar Hospital Department] Dakar Med 48 2003 185 188
J. Sakandé, M. Sawadogo, E.W. Nacoulma, E.S. Sidikath, E. Kabré, and S. Sawadogo Profil biologique de l'insuffisance rénale chronique Ann Biol Clin Que 43 2006 3 8
M.M. Gould, V. Mohamed-Ali, S.A. Goubet, J.S. Yudkin, and A.P. Haines Microalbuminuria: associations with height and sex in non-diabetic subjects BMJ 306 1993 240 242
C.R. Colson, K.E. De Greef, C. Duymelinck, P.J. Simoens, G.A. Verpooten, and M.E. De Broe Role of serotonin in the development of Chinese herbs nephropathy? Nephrol Dial Transplant 14 Suppl. 4 1999 16
C.R. Colson, and M.E. De Broe Kidney injury from alternative medicines Adv Chronic Kidney Dis 12 2005 261 275
J.Y. Guh, H.C. Chen, J.F. Tsai, and L.Y. Chuang Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan Am J Kidney Dis 49 2007 626 633
M.J. Klag, P.K. Whelton, B.L. Randall, J.D. Neaton, F.L. Brancati, and J. Stamler End-stage renal disease in African-American and white men, 16-year MRFIT findings JAMA 277 1997 1293 1298
C. Sabanayagam, A. Shankar, S.M. Saw, S.C. Lim, E.S. Tai, and T.Y. Wong Socioeconomic status and microalbuminuria in an Asian population Nephrol Dial Transplant 24 2009 123 129
J.S. Krop, J. Coresh, L.E. Chambless, E. Shahar, R.L. Watson, and M. Szklo A community-based study of explanatory factors for the excess risk for early renal function decline in Blacks vs Whites with diabetes: the Atherosclerosis Risk in Communities study Arch Intern Med 159 1999 1777 1783
K. Yamagata, K. Ishida, T. Sairenchi, H. Takahashi, S. Ohba, and T. Shiigai Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study Kidney Int 71 2007 159 166
A.X. Garg, B.A. Kiberd, W.F. Clark, R.B. Haynes, and C.M. Clase Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III Kidney Int 61 2002 2165 2175
K. Iseki, C. Iseki, Y. Ikemiya, and K. Fukiyama Risk of developing end-stage renal disease in a cohort of mass screening Kidney Int 49 1996 800 805
K. Yamagata, K. Iseki, K. Nitta, H. Imai, Y. Iino, and S. Matsuo Chronic kidney disease perspectives in Japan and the importance of urinalysis screening Clin Exp Nephrol 12 2008 1 8
N.M. Pakasa, N.M. Nseka, and L.M. Nyimi Secondary collapsing glomerulopathy associated with Loa loa filariasis Am J Kidney Dis 30 1997 836 839
L.M. Nyimi, E.K. Sumaili, C.B. Ebengo, F.B. Lepira, and N.M. Nseka Anomalies biologiques rénales chez les patients congolais VIH-positifs Congo Med 5 1998 230 233
W.E. Hoy, M. Rees, E. Kile, J.D. Mathews, D.A. McCredie, and D.J. Pugsley Low birthweight and renal disease in Australian aborigines Lancet 352 1998 1826 1827
W.E. Hoy, M. Rees, E. Kile, J.D. Mathews, and Z. Wang A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease Kidney Int 56 1999 1072 1077
P. Delanaye, E. Cavalier, J.P. Chapelle, and J.M. Krzesinski Importance of the creatinine calibration in the estimation of GFR by MDRD equation Nephrol Dial Transplant 21 2006 1130 1131
